Eli Lilly And Company (LLY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/08/25
Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, significantly improved progression-free survival in patients with treatment-naïve CLL/SLLPRNewsWire • 09/08/25
Eli Lilly And Company (LLY) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)Seeking Alpha • 09/05/25
2 S&P 500 Dividend Stocks That Could Climb More Than 20% According to Wall Street AnalystsThe Motley Fool • 09/05/25
Lila Biologics Announces Collaboration with Lilly For Radioligand Therapy Discovery and DevelopmentGlobeNewsWire • 09/04/25
Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain newly diagnosed metastatic KRAS G12C-mutant lung cancersPRNewsWire • 09/04/25
A Bad September to Remember? Time to Move to Safe Blue-Chip Dividend Stocks24/7 Wall Street • 09/01/25
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?Zacks Investment Research • 09/01/25
Novo's Wegovy Beats Lilly's Zepbound for Heart Health, Study Finds. What It Means for Stocks.Barrons • 09/01/25